OMRF scientists have identified a compound that could give birth to therapies for a host of eye diseases.
Dr. Gabriel Pardo helped develop the new multiple sclerosis medication Kesimpta and spoke about the drug.
The pair of four-year, $1.75 million NIH Research Project Grants, or R01s, will support separate projects.
The risk of heart failure increases as we age. OMRF is investigating why — and whether it can be stopped.
A recent discovery by scientists at OMRF could aid in the development of potential therapies for lymphedema.
The illness affects about 4,000 Americans, 80 percent of whom are women.